The Gores Group Completes Therakos Acquisition
Los Angeles-based private equity firm The Gores Group said today that it has completed the acquisition of Therakos, a New Jersey-based firm which provides systems used for immunomodulatory therapy. Financial terms of the buy were not announced. Therakos was part of Ortho-Clinical Diagnostics, Inc. Gores has named Michael Rechtiene as CEO of Therakos as part of the acquisition. Gores originally announced the acquisition in October.
posted on Wednesday, January 2, 2013

Related companies:
The Kriegsman Group

Related stories:
> Gores Group Buys Therakos
> Gores Group Completes Alpheus Acquisition
> The Gores Group Buys Touchscreen Interface Company
> The Gores Group Buys Slovenian Laser Maker
> The Gores Group Buys GE Healthcare Strategic Sourcing Home